Tag: irreversible electroporation
AngioDynamics completes enrolment for PRESERVE clinical study
AngioDynamics has announced the completion of enrolment and final treatment in its pivotal study of the NanoKnife system for ablation of prostate tissue in...
Preliminary results indicate IRE stimulates the immune response to improve survival...
Hester Scheffer (Amsterdam, The Netherlands) advocates for the use of combined irreversible electroporation (IRE) and other immune stimulatory therapies to achieve greater overall survival...
AngioDynamics receives FDA approval to initiate NanoKnife DIRECT clinical study for...
The US Food and Drug Administration (FDA) have approved AngioDynamic’s investigational device exemption (IDE) application for NanoKnife Irreversible Electroporation “Direct IRE Cancer Treatment” clinical...
Irreversible electroporation has “potential to become new standard of care” in...
A new study presented at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE 2016, 10–14 September, Barcelona, Spain) meeting finds that the treatment...
